{"cdcTestId":"2013-0428","testcaseName":"#2 @ 9 yrs, 4 wks - 0 days, female Cervarix ","vaccineGroup":"HPV","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2011-05-29T00:00:00","patient":{"dob":"2002-05-01T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2011-05-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-05-29T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2011-10-01T00:00:00","recommendedDate":"2011-11-01T00:00:00","pastDueDate":"2012-06-28T00:00:00"},"doses":[{"dateAdministered":"2011-05-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-05-29T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-15T08:40:47.581","generalDescription":"This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.","changedInVersion":"3.2","reasonForChange":"Updated to reflect ACIP recommendations for the HPV 2 dose series."}